This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Unity Biotechnology, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations in Retinal Treatment by Sharon Klier
Introduction
Sharon Klier is an accomplished inventor based in South San Francisco, CA. She has made significant contributions to the field of ophthalmology, particularly in the treatment of retinal diseases. Her innovative approach focuses on addressing retinal vasculopathies, which are critical conditions affecting vision.
Latest Patents
Sharon Klier holds 1 patent for her invention titled "Methods of treating retinal vasculopathies." This patent relates to methods for treating various retinal conditions, including diabetic macular edema, diabetic retinopathy, and age-related macular degeneration. The method involves administering a therapeutically effective dose of a specific compound to patients suffering from these conditions.
Career Highlights
Sharon Klier is currently associated with Unity Biotechnology, Inc., where she continues to advance her research and innovations in retinal treatments. Her work is pivotal in developing new therapeutic strategies that can significantly improve patient outcomes.
Collaborations
Sharon collaborates with Jamie Dananberg, who is also a key figure in her research endeavors. Together, they work towards enhancing the understanding and treatment of retinal diseases.
Conclusion
Sharon Klier's contributions to the field of retinal treatment exemplify the impact of innovative research on healthcare. Her dedication to improving the lives of patients with retinal vasculopathies is commendable and highlights the importance of continued innovation in medical science.